Johnson & Johnson's $13.1 Billion Acquisition of Shockwave Medical Expands MedTech Portfolio

Johnson & Johnson has acquired Shockwave Medical for $13.1 billion, aiming to bolster its presence in higher-growth markets and expand its expertise in cardiovascular intervention. Shockwave Medical specializes in intravascular lithotripsy, a technology that helps treat calcifications in the arteries, and the deal is expected to close in mid-2024. The acquisition is projected to be slightly dilutive to J&J's adjusted earnings for this year and the next, and analysts believe the offer fairly values Shockwave, with no anticipated antitrust issues due to a lack of product overlap.